Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TELBIVUDINE vs TENECTEPLASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TELBIVUDINE vs TENECTEPLASE: Safety Overview

Metric TELBIVUDINE TENECTEPLASE
Total FAERS Reports 434 1,319
Deaths Reported 27 310
Death Rate 6.2% 23.5%
Hospitalizations 106 314
Average Patient Age 43.4 yrs 66.2 yrs
% Female Patients 37.4% 43.7%
FDA Approval Date Apr 28, 2009 N/A
Manufacturer N/A Genentech, Inc.
Marketing Status Discontinued Prescription